Literature DB >> 10470139

Spectrum of extracellular matrix degrading enzymes in normal and malignant T lymphocytes.

D Hauzenberger1, S E Bergström, J Klominek, K G Sundqvist.   

Abstract

Human T cells produce and release fibronectin degrading neutral serine proteases with a molecular weight of 50 kD, 70-80 kD (doublet) and 95 kD and have a cell associated 400 kD fibronectin degrading enzyme. In addition, human T cells produce proteases with m.w. 50, 70-80 kD and 400 kD which degrade laminin. CD 4+ T lymphocytes from a non-malignant cloned human T cell line produce a 92 kD gelatinase (MMP 9) and malignant T cell lines release, in addition to the 92 kD gelatinase, low amounts of a 72 kD gelatinase (MMP 2). Purification of the enzymatic activities using benzamidine sepharose yields a 50 kD and a 70 kD band of which the 50 kD band has fibronectin degrading capacity. The purified enzymes do not react with monoclonal antibodies to various previously characterized proteolytic enzymes present in T cells. T lymphocytes from a non-malignant cloned human T cell line produce high amounts of the 50 and 70-80 kD proteases directly after stimulation with anti-CD 3 monoclonal antibodies whereafter the production of these enzymes declines with time. The expression of the 400 kD fibronectin-degrading protease is downregulated by crosslinking of alpha 4 beta 1-integrin receptors on T cells using monoclonal antibodies. Thus, T lymphocytes produce several matrix degrading enzymes with multiple substrate specificities. The expression of these enzymes is controlled partly by lymphocyte activation signals or by direct signalling via beta 1-integrins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10470139

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Matrix metalloproteinase-2 promoter genotype as a marker of cutaneous T-cell lymphoma early stage.

Authors:  Anna Vasku; Julie Bienertova Vasku; Miroslav Necas; Vladimir Vasku
Journal:  J Biomed Biotechnol       Date:  2010-06-29

2.  Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species.

Authors:  Tracy L Deem; Joan M Cook-Mills
Journal:  Blood       Date:  2004-07-20       Impact factor: 22.113

3.  Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer.

Authors:  Ali Naderi; Michelle Meyer
Journal:  Breast Cancer Res       Date:  2012-07-20       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.